☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
xencor
Xencor Reports the First Individual Dosing with XmAb942 in P-I/II Trial to Treat Inflammatory Bowel Disease
November 5, 2024
PharmaShots Weekly Snapshots (October 04 - 08, 2021)
October 8, 2021
PharmaShots Interview: Xencor's Bassil I. Dahiyat Shares Insight on the US FDA's Approval of COVID-19 Antibody Treatment Leveragin...
August 3, 2021
Top COVID-19 Deals (Part I): Biopharma Drug Development
April 17, 2020
PharmaShots' Most Read News of 2019
January 10, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.
